These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 28834194)

  • 21. Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis.
    Nart D; Arikan C; Akyildiz M; Yuce G; Demirpolat G; Zeytunlu M; Karasu Z; Aydogdu S; Killi R; Yuzer Y; Tokat Y; Kilic M
    Transplant Proc; 2003 Dec; 35(8):2986-90. PubMed ID: 14697957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modern-era successful liver transplantation outcomes in children with hepatic undifferentiated embryonal sarcoma.
    Rolfes PS; Yoeli D; Feldman AG; Adams MA; Wachs ME; Boster JM
    Pediatr Transplant; 2024 Feb; 28(1):e14645. PubMed ID: 38013236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of donor graft type on survival after liver transplantation for hepatoblastoma in children.
    Ziogas IA; Schmoke N; Yoeli D; Cullen JM; Boster JM; Wachs ME; Adams MA
    Pediatr Transplant; 2024 Feb; 28(1):e14641. PubMed ID: 37946593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for malignant diseases: selection and pattern of recurrence.
    Margarit C; Charco R; Hidalgo E; Allende H; Castells L; Bilbao I
    World J Surg; 2002 Feb; 26(2):257-63. PubMed ID: 11865357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation.
    Han S; Lee S; Yang JD; Leise MD; Ahn JH; Kim S; Jung K; Gwak MS; Kim GS; Ko JS
    Liver Transpl; 2018 Jan; 24(1):44-55. PubMed ID: 29024412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment of primary liver tumors in children: outcomes analysis of resection and transplantation in the SEER database.
    McAteer JP; Goldin AB; Healey PJ; Gow KW
    Pediatr Transplant; 2013 Dec; 17(8):744-50. PubMed ID: 23992390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation.
    Liu B; Teng F; Fu H; Guo WY; Shi XM; Ni ZJ; Gao XG; Ma J; Fu ZR; Ding GS
    BMC Gastroenterol; 2015 Oct; 15():138. PubMed ID: 26472203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
    Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
    Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
    Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.
    Court CM; Harlander-Locke MP; Markovic D; French SW; Naini BV; Lu DS; Raman SS; Kaldas FM; Zarrinpar A; Farmer DG; Finn RS; Sadeghi S; Tomlinson JS; Busuttil RW; Agopian VG
    Liver Transpl; 2017 Sep; 23(9):1123-1132. PubMed ID: 28688158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
    Agopian VG; Morshedi MM; McWilliams J; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
    Ann Surg; 2015 Sep; 262(3):536-45; discussion 543-5. PubMed ID: 26258323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Mehta N; Heimbach J; Lee D; Dodge JL; Harnois D; Burns J; Sanchez W; Roberts JP; Yao FY
    Transplantation; 2017 Sep; 101(9):2071-2078. PubMed ID: 28353492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy.
    Farinati F; Giacomin A; Vanin V; Sergio A; Burra P; Cillo U; Di Nolfo A; Del Poggio P; Benvegnu L; Zoli M; Borzio F; Giannini EG; Caturelli E; Cazzagon N; Rapaccini GL; Trevisani F;
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):195-202. PubMed ID: 22108511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
    Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM
    J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment.
    Ziogas IA; Ye F; Zhao Z; Matsuoka LK; Montenovo MI; Izzy M; Benedetti DJ; Lovvorn HN; Gillis LA; Alexopoulos SP
    J Am Coll Surg; 2020 Jun; 230(6):1035-1044.e3. PubMed ID: 32272204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.